Literature DB >> 8821595

Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans.

E W van Etten1, H R Chander, S V Snijders, I A Bakker-Woudenberg.   

Abstract

The in-vitro activities of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (AmB-DOC) against extracellular Candida albicans during 6 h of incubation in the presence of human serum were determined. With AmB-DOC inhibition of germ tube formation and effective killing were observed at AmB-concentrations of 0.8 and 3.2 mg/L, respectively. With AmBisome for both parameters tested, 32-fold increased AmB concentrations were needed. Preincubation of AmBisome in human serum for 6 h did not influence the rate of killing of C. albicans. Antifungal activity against intracellular C. albicans was assessed at 4 h and 24 h after incubation of C. albicans-infected monolayers of mouse peritoneal macrophages with antifungal agent. In the absence of antifungal agent C. albicans grows intracellularly by formation of germ tubes, and within 24 h mycelium is formed. Antifungal activity was evaluated in terms of both stabilization of the state of infection, as well as eradication of C. albicans from infected macrophages. For AmBisome stabilization only was observed at a concentration of 102 mg/L after 24 h of incubation. For AmB-DOC stabilization and eradication were observed only after 24 h of incubation at 0.8 and 1.6 mg/L, respectively. After previous exposure of macrophages to AmBisome for 6 h before infection, increased antifungal activity of AmBisome was observed: stabilization was observed at 4 h of incubation at 102 mg/L; at 24 h of incubation stabilization and eradication were observed at 25.6 mg/L and 102 mg/L, respectively. Prolongation of the exposure time before C. albicans infection from 6 h up to 24 h resulted in a further increase in antifungal activity of AmBisome. Localization studies of AmBisome and C. albicans in macrophages were performed using fluorescent-labelled C. albicans and fluorescent-labelled AmBisome. The presence of AmBisome within a macrophage was found not to influence uptake of C. albicans by the same macrophage, or vice versa.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821595     DOI: 10.1093/jac/36.6.961

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  Administration of liposomal agents and blood clearance capacity of the mononuclear phagocyte system.

Authors:  E W van Etten; M T ten Kate; S V Snijders; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

2.  Activity of liposomal amphotericin B with prolonged circulation in blood versus those of AmBisome and fungizone against intracellular Candida albicans in murine peritoneal macrophages.

Authors:  E W van Etten; W van Vianen; J Hak; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

3.  Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals.

Authors:  Qamar Zia; Owais Mohammad; Mohd Ahmar Rauf; Wasi Khan; Swaleha Zubair
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.